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http://www.biomedcentral.com/1471-2458/13/1169RESEARCH ARTICLE Open AccessWomen’s responses to changes in U.S. preventive
task force’s mammography screening guidelines:
results of focus groups with ethnically
diverse women
Jennifer D Allen1,2*, Shirley Morrison Bluethmann3, Margaret Sheets1, Kelly Morrison Opdyke4, Kathryn Gates-Ferris4,
Marc Hurlbert5 and Elizabeth Harden1Abstract
Background: The 2009 U.S. Preventive Services Task Force (USPSTF) changed mammography guidelines to
recommend routine biennial screening starting at age 50. This study describes women’s awareness of, attitudes
toward, and intention to comply with these new guidelines.
Methods: Women ages 40–50 years old were recruited from the Boston area to participate in focus groups
(k = 8; n = 77). Groups were segmented by race/ethnicity (Caucasian = 39%; African American = 35%; Latina = 26%),
audio-taped, and transcribed. Thematic content analysis was used.
Results: Participants were largely unaware of the revised guidelines and suspicious that it was a cost-savings measure
by insurers and/or providers. Most did not intend to comply with the change, viewing screening as obligatory. Few felt
prepared to participate in shared decision-making or advocate for their preferences with respect to screening.
Conclusions: Communication about the rationale for mammography guideline changes has left many women
unconvinced about potential disadvantages or limitations of screening. Since further guideline changes are likely to
occur with advances in technology and science, it is important to help women become informed consumers of health
information and active participants in shared decision-making with providers. Additional research is needed to
determine the impact of the USPSTF change on women’s screening behaviors and on breast cancer outcomes.
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Research has shown that having a mammogram can play a
critical role in early detection and treatment of breast can-
cer [1], the most common cancer diagnosis among women
worldwide [2,3]. Routine screening with mammography
has been a focus of cancer control efforts for the past quar-
ter century. Recommendations to begin routine screening
for women at age 40 have been in place in the US for two
decades [4]. However, the appropriate age to initiate and
intervals to continue routine mammography screening
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reproduction in any medium, provided the orInternationally, debate has surged around benefits of
mammograms against potential harms, most notably re-
lated to “over-diagnosis”. A recent meta-analysis conducted
by an independent panel of international scientists esti-
mated a 20% reduction in breast cancer mortality in
women that participated in screening over a 20-year period
based on data available from 11 randomized controlled tri-
als as well as observational studies [5]. However, based on
this data, they also estimated that 19% of the cancers iden-
tified in these patients may have constituted over-diagnosis
of cancers that would not have come to clinical attention
in those women’s lifetimes [5]. At present, the UK National
Health Service Breast Screening Programme invites
women ages 50–70 years for routine triennial screening,
but women within three years of this age range (47–49 andd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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self-referral [6].
In 2009, the US Preventive Services Task Force
(USPSTF) reviewed available evidence and recommended
that healthy women begin routine biennial mammograms
at age 50, a change from the previous recommendation to
begin routine annual mammograms at age 40 [7]. The
most compelling evidence in this decision came from com-
prehensive review of epidemiological studies which showed
limited long-term reduction of late-stage cancers in coun-
tries with similar screening practices; a tendency to “over-
diagnose” by 20-40% changes in breast tissue of younger
women being screened; and unnecessary radiation expos-
ure for women younger than 50 years [8-12]. Under the
new recommendations, US women younger than age 50
are advised to make individualized screening decisions in
consultation with their healthcare providers, after consider-
ing the potential benefits and harms of screening (‘in-
formed decision-making’) [7]. While these guidelines are
supported by many major US medical organizations [13],
debate persists in the scientific community, especially as
other major cancer authorities, such as the American
Cancer Society, continue to recommend routine annual
mammograms beginning at age 40 [14]. These conflicting
recommendations have contributed to a climate of confu-
sion for both providers and patients [15-17].
Researchers have begun to assess the effects of this de-
bate on public perceptions about mammography [18]. Early
reports have suggested that the new guidelines have had lit-
tle impact on mammography rates among women ages 40–
50 [19]. In a randomized controlled trial in which 249
women 39–49 years were exposed to two types of media
reports around the 2009 guideline changes, 84% said they
would not delay routine screening exams to age 50, even if
their doctor made that recommendation [20]. Women who
had experienced a prior false-positive mammogram were
found to be less likely to adhere to the new guidelines and
to over-estimate their lifetime risk of breast cancer [20].
Some researchers contend that women have been more re-
ceptive to past recommendations because they focused on
earlier and more frequent screening [21] – a by-product of
what some have called an “enthusiasm for cancer screening”
in the US [22]. But, generally, women and physicians report
low screening knowledge and low engagement in shared
decision-making about breast cancer screening [23-25].
Recent studies suggest a need for greater exploration of
the impact of changes in screening recommendations, and
on how decisions related to mammograms are made
[26,27]. This may be especially important for minority and
immigrant women, for whom cultural factors may shape
attitudes and beliefs about the importance and harms of
breast cancer screening [28,29]. Despite recent studies
that affirm persistent disparities in screening access and
treatment for breast cancer, [30-33] the USPSTFguidelines do not address racial/ethnic differences in
breast cancer incidence or mortality, leaving room for de-
bate on their applicability to specific populations [7,34].
There is also a lack of empirical data to assess the impact
of recent policy changes on mammography uptake
[35,36].
Understanding the extent to which women are aware of
guideline changes, the controversy that has erupted, and
how they reconcile inconsistent messages from a variety of
information sources is critical to developing interventions
that can improve decision-making processes related to
breast cancer screening. A few recent studies have begun to
assess attitudes, knowledge and potential interventions for
appropriate use of mammograms [37,38]. Yet more specific
exploration of communication needs, especially for diverse
women, is needed. This qualitative study explored know-
ledge, awareness and attitudes about breast cancer screening
and the USPSTF guideline changes among Latina, African
American and Caucasian women. Discussions also assessed
women’s information needs, decision-making processes, and
preferred channels and sources of information delivery.
Methods
We selected focus group methodology for our qualitative
data collection, as it offers several advantages over other
methods. With this method, participants share a range of
perspectives, allowing each to consider the extent to
which her experience is similar to or different from those
expressed by the others. This process can facilitate a more
thorough exploration of an individual’s own experience.
Also, focus group methodology makes the researcher a less
commanding or controlling presence, thereby allowing par-
ticipants to more easily express their opinions and percep-
tions. As a result, the discussion may uncover themes that
could shed new light on key aspects of the phenomena of
interest. Finally, the collective context of focus groups en-
ables pertinent themes to arise more quickly than they
might during individual interviews [39,40].
Our focus group discussion guide consisted of a list of
open-ended questions (Table 1) based on our previous
work [41-43] and the few existing studies of women’s reac-
tions to changes in cancer screening guidelines [18,20].
Data were collected between February and April 2011. Eli-
gible women were between the ages of 40–50 and were
English or Spanish speaking. Women (n = 77) were re-
cruited through word-of-mouth, fliers, and by personal
contact with research assistants in community and social
service agencies, housing developments, and churches in
the Greater Boston metropolitan area. Written informed
consent was obtained from the participants prior to partici-
pation. Focus groups took place at YWCAs in three com-
munities and at a community health center. Data collection
ceased at the point of saturation, that is, when no new
themes emerged.
Table 1 Focus group questions
Construct Sample question
General health What health issues are you most concerned about, for yourself?
What do we know about the causes of breast cancer? What have you heard?
What do women do to prevent breast cancer?
How do you find out if you have breast cancer?
What do you think is the most important thing women can do to detect breast cancer early?
If no one mentions mammograms, ask, “Have you heard about mammograms? What have you heard?”
Mammograms When should you get your first mammogram? At what age?
How often should you have a mammogram after that?
Who makes these recommendations?
Have you seen or heard anything recently about changes in these recommendations?
How did hearing or seeing this information make you feel?
Screening guidelines and changes
in screening guidelines
What are your thoughts and concerns about these changes?
Why do you think the guidelines changed?
What makes you think the guidelines changed because of < insert participants’ answer > ? (probe)
How does the change make you feel?
Do you think the guidelines will change again? Why or why not?
How would you feel if the guidelines changed again?
How do you think the change in the mammography screening guidelines will affect you?
Decision making Think about a time when you had to make a health decision for yourself or some one in your family.
Did you want to talk about it with your health care provider?
What made you want to discuss it with your provider?
What did you want to know?
How did your provider respond?
How did you feel about that response?
What would have made that experience more successful for you?
Education What do you think is the best way for women to learn about this issue, making decisions about mammograms?
Probes:
From their providers
Health education materials (from where? Insurer?)
Provider? News outlets? Online?
Peer health leaders or navigators
What do you think are the 3 most important things women in their 40s need to know?
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studies have shown that these groups may have distinct be-
liefs and attitudes about screening [44,45]. There were 8
groups with 6–10 women in each. Trained moderators
were matched according to the race/ethnicity and language
of each group and conducted the groups according to a
standardized protocol. Each group discussion was audio-
taped, professionally transcribed and where necessary,
translated. A note-taker was present to document non-
verbal communication and observe participants’ levels of
participation. Each session lasted between 60–90 minutes
and participants each received $50. All study protocols andprocedures were approved by the Institutional Review
Board at the Harvard School of Public Health.
Analysis
Constant comparative analysis of transcripts was con-
ducted, based on procedures outlined by Strauss and
Corbin [46]. Three of the authors (JDA, SMB, MS) inde-
pendently reviewed each transcript using open coding to
create categories. Subsequently, the investigator team
reviewed the categories and supporting quotes to develop
an initial coding scheme. Through this process, open codes
were collapsed into higher order categories that reflected
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transcripts were reviewed further and discussed until con-
sensus was achieved [47].Results
Characteristics of participants
We conducted eight focus groups with a total of 77 partic-
ipants. As shown in Table 2, 35% were African American,
26% Latina and 39% were Caucasian. Two of the focus
groups were conducted in Spanish. The mean age of par-
ticipants was 44.6 years.Themes
Following the multi-stage coding process, we grouped pre-
dominant themes into three categories: (1) knowledge,
awareness and attitudes toward mammograms and the
USPSTF guideline change; (2) decision-making with re-
spect to breast cancer screening; and (3) preferences re-
garding channels and sources for information. See Table 3
for predominant themes and supporting quotes.Table 2 Socio-demographic characteristics of focus
group participants
Characteristic N (77) (%)
Age (mean, sd) 77 44.6 (4.3)
Educational Level
< HS 5 6.5
HS or GED 16 20.8
Some College or technical school 32 41.6
College graduate or higher 24 31.2
Annual Household Income
< Less than $10,000 12 15.6
$10,000 $29,999 16 20.8
$30,000 - $49,999 24 31.2
More than $50,000 20 26.0
Don’t know/not sure 4 5.2
Missing 1 1.3
Insurance status
Insured (private) 38 49.4
Insured (public) 23 29.9
Insured (type missing) 7 10.4
Not insured 8 9.1
Missing 1 1.3
Race/Ethnicity
White, non-Hispanic 30 39
Black, non-Hispanic 27 35
Hispanic 20 26Knowledge, awareness and attitudes regarding USPSTF
guideline changes
The majority of participants were unaware of any change in
mammography screening guidelines; only two or three
women in each focus group reported knowing of the
change. The others were unaware of the recent debate
within the medical community about the appropriate age
and interval for mammography screening, although some
noted that they had heard about this in the past (referring
to earlier guideline changes). When informed about the re-
cent change, many expressed disbelief and confusion. One
participant said, “I don’t understand why we (shouldn’t) get
our first mammogram til after 40, if nowadays there is so
much cancer among younger people” (Latina).
A suspicion held by many women was that the guide-
line changes were motivated by cost-cutting measures.
For example, “I really think that [the change] comes
from the insurance companies. They do not want to
pay for an exam every year” (Latina). Others noted, “In-
surance companies tell doctors what to do” (African
American) and “Yes. That’s what I think. I just think it’s
the insurance companies. Sorry” (Caucasian). Discus-
sions in each of the groups involved the notion that in-
surance companies were not acting in women’s best
interests. Many expressed fears that under the new
USPSTF guideline, insurance companies would no lon-
ger cover mammograms for women under 50.
Other participants expressed feeling betrayed by the
process for revising the mammography recommendations,
since they believed that women should have been con-
sulted before the new guidelines were established. For ex-
ample, one participant asked: “Who asked me? Did they
ask women how they would feel if it was changed to 50? Or
did they change it first and now they are asking me after
the fact?” (Latina). Others expressed the opinion that it
was paternalistic for presumed “experts” to decide which
would result in greater harm, over-detection and diagnosis
or heightened anxiety and fear. One woman commented,
“I was…almost MAD at the news…they’re belittling us, that
we can’t handle it…you know, the false positives,” (Cauca-
sian). Multiple women in the Caucasian groups said they
strongly believed in the importance of mammograms for
early detection and “protection” against breast cancer. A
theme that was particularly apparent among the focus
groups with African American women was that the guide-
line change signified withdrawal of access to an important,
potentially “life-saving” procedure.
Although there was consensus for at least an annual
mammogram, there were frequent comments regarding
the fear, discomfort and anxiety that accompanied
breast cancer screening. Women shared stories about
missed diagnoses, false positive findings, and painful
diagnostic procedures. Still, most said that they would
continue with routine screening. Indeed, many said that
Table 3 Themes and sample quotes
Theme Sample quotes
Knowledge, awareness & attitudes toward mammography screening guideline changes
Low levels of knowledge & awareness; confusion o “I think that we, as Hispanic women, sometimes have little knowledge.
That’s why we are the most exposed to cancer, to die from it.
So many people lack the right information.” (Latina)
o “The guidelines have changed without us even knowin’, evidently.
Because we don’t know about it.” (African American)
o “I’m very confused by that because of, you know, I think it was about
a year ago …they kind of changed what they were saying…” (Caucasian)
o “If my doctors tell me that I still need it every year, is my insurance then telling
me I’m not?… it just added confusion, that STILL isn’t resolved.” (Caucasian)
Belief that screening more often & at younger ages is best o “I don’t understand why do we get our first mammogram after 40,
if nowadays there is so much cancer among younger people.” (Latina)
o “There are so many cases of women (with cancer). I don’t even know why we
are discussing (raising age of first mammogram). It is not logical to me.” (Latina)
o “Since there is cancer in people who are so much younger, starting at 50
or asking the doctor at 40 doesn’t make sense.” (Latina)
o “In our ethnic group, we already have women diagnosed with
breast cancer in their 20s. Why not start early.” (Latina)
o “[Yearly mammogram have] been drilled in our head for years and years and
years and then, all of a sudden you’re just changing it, just like that.” (Caucasian)
Mistrust regarding rationale for change o “I really think that that comes from the insurance companies…
(who will not) want to pay for an exam every year.” (Latina)
o “Insurance companies tells doctors what to do.” (African American)
o “This is something someone told me long ago; the notion that
(current screening guidelines are) not cost-effective…I am sorry.
Life is more important than ‘cost-effective.’” (Latina)
o “… the sense I got was, ‘Okay, they’re belittling us, that we can’t handle it…
you know, the false/positives.’ Then my interpretation was, ‘Well, it’s cost-cutting’ …
what I was hearing… didn’t [make] sense.” (Caucasian)
o “They’re trying to save a dollar.” (Caucasian)
Excluded from decision-making & policy process o “Who asked me?…Did they ask women how they would feel if it was changed to 50?
Or did they change it first and now they are asking me after the fact?” (Latina)
o “Is… the government trying to dictate when a
woman needs a screening test?” (Latina)
o “I don’t accept [the change] it because I feel that it should have been…told to
everybody …there’s a lot of people in here and only one person heard about it,
the word has to get out… women need to know what’s goin’ on!” (African American)
o “It was just, ‘Here’s the change, now do it this way.’
Without any explanation.” (Caucasian)
o “It was like, ‘Well, they’re not gonna know better,’ type of thing.
They’re just women. It was just men, deciding FOR us. I felt very diminished,
the way they were talking about me [about] women in general.” (Caucasian)
Factors that influence decisions to undergo breast cancer screening
Not a decision o “I would still want my mammogram done, no matter what.
I’m forty-seven and I’ve had problems in the past…I would
still like to be on the safe side.” (African American)
o “(If my doctor told me not to have a mammogram) I would think
somethin’ is wrong with her. Why is she tellin’ me NOT to have it done?
Shouldn’t it be my choice?” (African American)
o “(If the doctor told you not to have a mammogram), I would just say,
‘I don’t feel comfortable, and I just feel like I need to have one.’” (African American)
o “I would tell the doctor that if he is not willing to refer me to do
the (mammogram) that I’ll go somewhere else. Because I’m worried…” (Latina)
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Table 3 Themes and sample quotes (Continued)
“Following doctor’s orders” o “The doctor decides whether or not you get a mammogram.” (Latina)
o “In my case, I didn’t have to (schedule my mammogram) myself,
because they, my doctors, take care of it and refer me to the
appointment every year…But if they didn’t do it, I would.” (Latina)
o “I got my mammogram three times and the last two times, they told me I had a cyst
on one of my breasts. So, I asked them, ‘what are you going to do to remove it? Am I
going to get surgery?’…(The doctor) told me…only if I wanted to. And I think that’s
wrong. They have to do what needs to be done…Not leave it up to me.” (Latina)
o “Well, you know what I noticed? A lot of women in our community, right here,
are not educated enough to know that they can (decide to have a mammogram
on their own)…they just go by what their doctor says.” (African American)
Need to advocate for oneself o “A lot of women in our community, right here, are not educated enough
to know that they can (decide to have a mammogram on their own)…
they just go by what their doctor says.” (African American)
o “I wouldn’t follow the guidelines. (I’d still get a mammogram) once a year.” (African
American)
o “Do your research, ask your questions, it’s you and you only
have one body, one life.” (African American)
o “I think women stood up and said, ‘No, you’re not gonna change.
This is our health.’” (Caucasian)
Preferred sources & channels for information delivery
Doctors are preferred information source but
many have poor patient/provider communication
o “I told (the doctor) I was still concerned about a spot (on my breast). But the doctor
made a dismissing (sic) gesture and said, ‘You don’t need an ultrasound. You just need
a mammogram. You are fine. I don’t see any spot,’ as if it were unimportant.” (Latina)
o "Don“t sit back and think that the doctor’s gonna go through all this and that
because, you know, the doctor’s mind might be somewhere else…” (African American)
o “What do I think doctors will do? Some doctors will be COMPLETELY
disrespectful of their patient’s thoughts in this situation and say,
‘You don’t know anything. What do YOU know?’” (African American)
o “I would be interested in potentially making that
decision or talking to my doctor.” (Caucasian)
More information & explanation needed; help women make
informed decisions & advocate for their preferences
o “If my doctor told me not to have a mammogram, I would think
somethin’ is wrong with her. Why is she tellin’ me NOT to have it done?
Shouldn’t it be my choice?” (African American)
o “The thing that bothers me about this, it says, ‘women who are less than 50
have to decide if they want.’ Okay. So, first of all, HOW they decide is really
important; who helps them decide – I’m worried about that.” (African American)
o “The medical professionals need to be more proactive in helping women
understand… especially in the Black community. All of those screenings
should be discussed, but they’re not....” (African American)
o “I’m thinking, ‘Gee, what ARE the cons?’ … But, that discussion didn’t happen.
They always ask, ‘Do you have questions?’ But I didn’t get the idea that it was
up for discussion. It was kind of like, ‘I’m gonna write you a referral for your
mammogram.’” (Caucasian)
o “You NEED that information from people that you trust
so that you can make a decision.” (Caucasian)
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to start at a younger age (<40).
Decision-making with respect to breast cancer screening
Given the low levels of knowledge about the guideline
change, many women acknowledged that they simply
“followed doctor’s orders,” rather than taking part in
decision making. One participant stated, “A lot of
women in our community. . .are not educated. . .they
just go by what their doctor says” (African American).Others commented that they would defer to the doc-
tor’s recommendation, even if it conflicted with their
own preference. “I assumed (getting a mammogram)
was best for me, and that’s what I did. I didn’t question
it. So if that means I’m gonna have to pay for it, I will
take care of myself and I will have it done. I thought
that was the best thing to do,” (Caucasian). A smaller
number of women expressed support for shared deci-
sion making “The decision to have a mammogram is be-
tween you and your doctor. . ”. (African American).
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often accompanied by discussion of how women often
leave decisions to their providers. The juxtaposition of
these two themes led to lengthy discussions about the
need for women to become better advocates for them-
selves. Although few women reported that they felt
confident taking an active role in medical decisions them-
selves, many said that they would strongly urge their peers
to be more active in the decision-making process. One re-
spondent advised, “Do your research, ask your questions;
it’s you, and you only have one body, one life” (African
American). Some women also felt that women younger
than 50 should be educated about their “right to be
screened”. This was evident in the quote from one woman
who stated, “We want to make sure that if you’re younger
than 40 AND you feel like that’s what you need [a mam-
mogram] . . . there needs to be a way . . . to get [one]. It’s
not just a ‘NO, you can’t get it” (African American). The
notion that one needed to be prepared for a discussion of
mammography with one’s provider was particularly preva-
lent among African American women; Latinas were less
likely to express a need to prepare for the discussion and
more likely to report that they would defer to the pro-
viders’ recommendation.
Learning about the revised guidelines seemed to
strengthen rather than diminish women’s commitment to
mammography screening. Quotes such as, “I won’t follow
the guidelines. I’d still get a mammogram once a year,”
(African American) were common. Others suggested the
doctor would be negligent if he or she did not recommend
screening, for example, “If my doctor told me not to have a
mammogram, I would think something is wrong with her,”
(African American). Another said that she would not trust
a doctor who told her not to be screened, saying: “I would
tell the doctor that if he is not willing to refer me to do the
(mammogram) that I’ll go somewhere else” (Latina).
Preferences regarding channels and sources for information
Although most participants cited their medical providers
as their preferred source of health information, most
expressed dissatisfaction with the frequency and quality of
conversations with them. Many also shared experiences of
having doctors minimize their concerns: “I told (the doc-
tor) I was still concerned about a spot (on my breast). But
the doctor made a dismissing gesture and said, ‘You don’t
need an ultrasound. You just need a mammogram. You
are fine. I don’t see any spot,’ as if it were unimportant”
(Latina). Regarding mammography, one woman expressed
concern that many women aren’t able to stand up for
themselves and express their preferences to their pro-
viders. She stated, “I’m gonna keep standing for women
who don’t have that opportunity [to express their prefer-
ences], cause I have BEEN in that place! What do I think
doctors will do [if women want a role in decision-making]?Some doctors will be COMPLETELY disrespectful of their
patients’ thoughts in this situation and say, ‘You don’t know
anything.“ What do YOU know?” (African American)
Among the Latina focus groups, the influence of family
members’ opinions was clearly evident. There were mul-
tiple stories about receiving health advice from mothers or
grandmothers. One participant stated, “… Latino women
rely a lot on what our grandmothers taught us: ‘In case of
any pain, you take a hot tea.’” Another shared: “Latino
women rely on information/folk cures shared through gen-
erations”. When asked specifically about making a decision
about whether or not to have breast cancer screening, one
woman stated: “In a situation like that, what you need the
most is the support from your family”. (Latina).
When presented with the idea of a print brochure to
assist with informed decision-making about mammog-
raphy—including information about both pros and cons
of screening– women were divided. Most expressed that
they would have “no use” for a decision aid because they
planned to get screened regardless of screening guide-
lines. In all of the groups, women expressed skepticism
about the information regarding disadvantages of mam-
mography. Multiple Caucasian women said that they
needed mammograms because they believed “early detec-
tion is everything” and mammograms were central to this
belief (Caucasian). In other groups, the rejection of the po-
tential disadvantages of mammograms was more blatant.
One woman went so far as to say: “This information is full
of [expletive]” (African American). A few acknowledged
that there might be some merit in such an educational bro-
chure, but remained concerned about their ability to sift
through inconsistent information about mammography or
“go against” what their provider recommended. There was
also fear about insurance coverage. One woman put it this
way, “The thing that bothers me about this [brochure], is it
says, “Women who are less than 50 have to decide if they
want [a mammogram].‘ Okay. So, first of all, HOW do they
decide? Who helps them decide? I’m worried about that.
Secondly, is it going to be covered if you DO decide [to be
screened]?” (African American).
Comparing responses between women of different
ethnic groups In analyzing the data, the authors were
careful to ensure that the emerging themes fairly repre-
sented women across all three racial/ethnic groups in-
cluded in the study (Table 3). However, there were some
general variations in how these themes related to each
racial/ethnic group that may be important to highlight.
For example, Caucasian and African American women
seemed to be the strongest proponents of retaining the
practice of annual mammograms beginning at age 40.
Caucasian women, in particular, seemed to place high
value on the current culture of breast cancer awareness
and perceived role of mammograms in the breast cancer
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support of earlier guideline recommendations partly be-
cause they felt familiar. As previously discussed, there
was also a resistance to guideline changes among these
women because the process by which they were revised
did not recognize their part in the decision, a sentiment
that was echoed among Latina women. Of all three groups,
Latina women seemed least confident about advocating for




Many women in our sample were not aware of the change
in the USPSTF mammography screening guidelines or
knowledgeable about the reasons for the policy change.
Upon learning of the change, most women expressed
strong opposition. There was a deep sense of mistrust re-
garding the underlying reasons for the guideline change,
with many assuming that there was a financial motive
among insurance companies, providers, or both to limiting
access to screening. Moreover, there was a sense of injust-
ice that the lay public had been excluded from the policy-
making process. Many questioned the ability and authority
of “experts” to weigh the potential benefits and harms of
screening on behalf of individual women.
Many participants perceived that an important
service– one that women cited as essential to breast
cancer survival– had been “taken away” from them.
This sentiment was particularly prevalent in discussions
among African American women. This finding is con-
sistent with recent literature on medical mistrust that
has identified suspicion and lack of support from health
care professionals as key factors associated with under-
utilization of screening, especially among women of ra-
cial/ethnic minority groups [48]. Mistrust of medical
providers, researchers and the healthcare system, which
is deeply rooted in historical injustices, has been a con-
siderable impediment to receipt of all kinds of health
services [49,50].
Given this evidence, it is difficult to predict whether
greater involvement with providers would necessarily in-
fluence appropriate use of mammograms without signifi-
cant trust-building efforts.
When asked for their opinions about guidelines, many
participants expressed a desire to start screening at age
40 (or before), to decrease the time interval between
screenings, in fact, there was some thought that there
should be no upper age-limit for screening. Although a
key element of the USPSTF recommendation is that
women make individualized, informed decisions about
mammography in partnership with their health care
providers, few felt confident in their ability to do so. A
more commonly held view was that a woman shouldfind a place to obtain screening or to seek a different
provider if they were advised against screening. Al-
though there was discussion about the need to advocate
for oneself, this was not something most women felt com-
fortable or equipped to do. Nor did they see screening as a
decision to be made; the notion of weighing benefits ver-
sus harms seemed irrelevant to many women. Participants
viewed the potential adverse effects of screening, including
over-diagnosis, over-treatment and radiation exposure
[51], as minimal and worth the risk if it could save their
lives from breast cancer. As one participant stated, ““The
benefits of screening WAY outweigh the harms,” (African
American).
An unexpected finding was that a substantial number of
women in this study felt they were “excluded” from the
policy making process. This may have been related to the
timing of announcements related to the guideline change,
which coincided with news of health care reform, poten-
tially stoking fears that the change was a cost-savings
measure [7]. In the future, dissemination of information
about guideline changes might utilize community-based
participatory strategies, which involve all stakeholders (in-
cluding women) in the process. Such approaches can foster
trust between and be mutually beneficial to policymakers
and community members [52]. Even though the review of
scientific evidence underlying policy may require a level of
scientific expertise that cannot be expected of the lay pub-
lic, the development of health messages, communication
strategies, and consideration of timing of announcements
regarding guideline changes could certainly benefit from
lay involvement. Such involvement could also go a long
way to dispel fears or suspicions [53].
We recognize there are limitations to this exploratory
study conducted among a convenience sample. Our goal
was not to obtain a representative sample, but rather to
hear from women from varied backgrounds and with di-
verse perspectives [54,55]. Our sample was relatively large
for a qualitative study, which gives us confidence that the
themes most prevalent in this group could resonate with
similar groups of women. We also found that our results,
particularly around low awareness and knowledge about
the rationale for the USPSTF guideline changes, were con-
sistent with the findings of similar studies [18,39,40], al-
though to our knowledge, this is the first study of its kind
to assess awareness across multiple racial/ethnic groups.
We also acknowledge that those who volunteered to
participate may have been more interested in and
knowledgeable about the topic as compared with the
general population. If that were the case, these findings
further underscore women’s need for information. An-
other limitation is that we were not able to explore dif-
ferences across the myriad groups that constitute the
three major racial/ethnic groups included in this study,
for example by region or country of origin. We recognize
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source limitations prohibited from segmenting focus
groups on these factors.
Despite these limitations, the focus groups approach en-
abled us to identify participant-driven themes, illuminating
variations in perspectives. The data are useful in generating
hypotheses that can be tested in future research. Moreover,
these findings provide insights for the development of inter-
ventions to address the recent guideline change.
Intervention opportunities
Awareness of guideline changes was low in this sample, so
targeted efforts to increase knowledge and awareness of
changes in mammography recommendations are needed.
However, simply increasing knowledge and awareness will
not be sufficient. Our findings suggest that contextual fac-
tors – including community and cultural norms, as well as
issues of medical mistrust and fear – need to be addressed
when conveying changes in screening guidelines, particu-
larly if recommendations call for less (not more) screen-
ing. Changing social norms about breast cancer screening
may require undoing much of the health messaging that
has been delivered over the past several decades. Numer-
ous studies document the fact that women overestimate
their risk of breast cancer [56,57] and underestimate the
fallibility of mammography [58]. Since prior research
shows that social norms and perceptions about the im-
portance of mammography to family members can affect
screening practices [59-63], interventions are needed to
normalize the idea that one might choose to forgo cancer
screening in some circumstances. This will require quite a
bit of ‘undoing’ prior public health campaigns that stressed
“get a mammogram, once a year for life”. In such a context,
hearing similar age peers, family members or role models
talk about their reasons for choosing not to undergo
screening at a young age could help others to see that this
could be a reasonable choice, given the tests’ limitations
and potential for adverse outcomes. Moreover, since
screening guidelines are likely to change in the future as
new technologies are tested and put into practice, a focus
on helping women to become more “informed consumers”
of health information might be a more important interven-
tion goal, rather than instilling the directive from prior
campaigns: “Get a mammogram”.
Many women expressed that they preferred to receive in-
formation about breast cancer screening directly from their
providers, although there were some differences observed
across racial/ethnic groups. Latinas frequently reported that
they relied on female family members for health advice, but
many also reported that they “followed doctor’s orders”
without question. Among African American women, mis-
trust of provider motives was more often discussed, and
with this came with the perception that women need to ad-
vocate for themselves by preparing themselves withinformation. Although many of the Caucasian women also
expressed a belief in the importance of shared decision-
making, none reported having a specific positive experience
with shared decision-making. Experiences of poor patient-
provider communication were frequently reported across
all of the groups, and many women were pessimistic about
the idea that medical decisions could truly be shared.
Our original plans for this formative research had been
to use the results to develop a decision aid for women ages
40–50 so that they would be better informed about mam-
mography screening, and therefore, more prepared to par-
ticipate in shared-decision making. However, our findings
suggest that women do not see the relevance of decision
aids in the context of breast cancer screening. For the
most part, women did not see that there was a decision to
be made; they simply wanted to be screened for breast
cancer. However, as most women wanted more informa-
tion about breast cancer, yet eschewed decision aids (per-
haps due to lack of full understanding of their educational
nature), other types of targeted communication efforts
may be needed to improve patient-provider communica-
tion. Contextualizing breast cancer outreach and resources
in light of cultural considerations may support acceptance
and participation in informed decision-making activities
[64]. The prominence of self-advocacy in our discussion
themes also provides an opportunity to consider ways of
positioning judicious use of mammography as something
that may be the most beneficial course of action.
Interventions to equip women with the information they
need to make informed decisions, as well as dyadic inter-
ventions to improve communication skills between pa-
tients and providers are needed. The latter is a particular
challenge, as time for a routine medical visit averages
just 21 minutes in U.S. primary care practices [65]. Use of
e-Health technology, including multi-media educational
tools, can help convey complicated messages without taking
time away from the visit [66]. In similar research related to
prostate cancer screening, simple informational tools, such
as fact boxes that list out screening harms and benefits,
were suggested for communicating screening decisions
[67]. More research is needed to assess how communica-
tion tools can be used by patient navigators or outreach
workers, who provide direct breast health information and
often influence women’s decisions about screening [68].
Women also suggested that making decision support or
educational tools available outside of clinical settings, for
example, in familiar community settings, would be useful.
A number of African American women advised sharing in-
formation in locations they visited regularly, such as
churches, grocery/corner stores, libraries, laundro-mats,
schools and health clinics. Latinas agreed and suggested
social settings frequented by members of their communi-
ties, including local restaurants and food stores. Distribu-
tion of information in socially relevant community settings
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[69-71], and should continue to be a part of comprehensive
breast cancer control efforts.
Conclusion
Future studies with larger samples of ethnically diverse
women are needed to verify these findings and could
identify themes specifically related to cultural influences
on attitudes, beliefs, and knowledge. Additionally, since
prior research has suggested that knowledge and uptake of
screening decision aids may vary with SES and other char-
acteristics [72], a comparison with women of varying SES
levels could be useful. Additional research that evaluates
the short- and long-term effects of guideline changes, in-
cluding women’s adherence to screening guidelines and
provider practices/recommendations, as well as breast can-
cer morbidity and mortality, is needed. As the evidence
base for breast cancer screening continues to grow and as
new technologies become available, it is likely that screen-
ing recommendations will continue to evolve. Given that
change is inevitable, preparing women to be informed con-
sumers of information regarding the efficacy of available
screening modalities and providing them with skills to
make informed decisions with their health care providers
should be a primary goal for cancer control interventions.
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